[The beginning of the end for interferon therapy? - novel interferon-free treatment options for hepatitis C]
- PMID: 24824911
- DOI: 10.1055/s-0034-1366260
[The beginning of the end for interferon therapy? - novel interferon-free treatment options for hepatitis C]
Comment on
-
Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection.N Engl J Med. 2014 Jan 16;370(3):211-21. doi: 10.1056/NEJMoa1306218. N Engl J Med. 2014. PMID: 24428467 Clinical Trial.
-
Phase 2b trial of interferon-free therapy for hepatitis C virus genotype 1.N Engl J Med. 2014 Jan 16;370(3):222-32. doi: 10.1056/NEJMoa1306227. N Engl J Med. 2014. PMID: 24428468 Clinical Trial.
Similar articles
-
Viral hepatitis: new hepatitis C therapies-a medical pick and mix.Nat Rev Gastroenterol Hepatol. 2014 Jun;11(6):329. doi: 10.1038/nrgastro.2014.64. Epub 2014 Apr 29. Nat Rev Gastroenterol Hepatol. 2014. PMID: 24776807 No abstract available.
-
Combination of daclatasvir and sofosbuvir for hepatitis C genotypes 1, 2, and 3.Gastroenterology. 2014 Aug;147(2):534-6. doi: 10.1053/j.gastro.2014.06.016. Epub 2014 Jun 20. Gastroenterology. 2014. PMID: 24953626 No abstract available.
-
Daclatasvir plus sofosbuvir for HCV infection.N Engl J Med. 2014 Apr 17;370(16):1560. doi: 10.1056/NEJMc1401726. N Engl J Med. 2014. PMID: 24738675 No abstract available.
-
Daclatasvir plus sofosbuvir for HCV infection.N Engl J Med. 2014 Apr 17;370(16):1560-1. doi: 10.1056/NEJMc1401726. N Engl J Med. 2014. PMID: 24738674 No abstract available.
-
Citius, Altius, Fortius: The New Paradigm in the Treatment of Chronic Hepatitis C Disease.Clin Infect Dis. 2018 Jan 18;66(3):464-474. doi: 10.1093/cid/cix746. Clin Infect Dis. 2018. PMID: 29020275 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources